Randomized phase II study of adjuvant WT1 vaccine (SLS-001) for malignant pleural mesothelioma (MPM) after multimodality therapy Meeting Abstract
| Authors: | Zauderer, M. G.; Dao, T.; Rusch, V. W.; Ginsberg, M. S.; Tsao, A. S.; Panageas, K.; Stergiou, A. M.; Scheinberg, D. A.; Krug, L. M. |
| Abstract Title: | Randomized phase II study of adjuvant WT1 vaccine (SLS-001) for malignant pleural mesothelioma (MPM) after multimodality therapy |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 439s |
| Language: | English |
| ACCESSION: | WOS:000404711505251 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.8519 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 8519 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
